Related Experiment Video
Updated: Aug 19, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
The coming decade in precision oncology: six riddles
Adam Wahida1,2,3,4, Lars Buschhorn5,6, Stefan Fröhling7,8
1Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Neuherberg, Germany. adamwahida@gmail.com.
Precision oncology personalizes cancer treatment using omic data for better outcomes. Solving key challenges in molecular and immune profiling is crucial for optimizing targeted therapies and immunotherapy.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- High-throughput omic analyses have advanced cancer research into the precision oncology era.
- Personalized treatment is essential as each patient's cancer exhibits unique molecular and immune characteristics.
- Targeted therapies and immunotherapies are transforming cancer care, with previously undruggable pathways becoming accessible.
Purpose of the Study:
- To discuss critical challenges in optimizing precision oncology for lethal malignancies.
- To highlight the importance of personalized treatment strategies based on individual tumor landscapes.
- To identify key areas for future research in precision cancer medicine.
Main Methods:
- Review of current high-throughput omic investigation methods.
- Analysis of molecular and immune landscapes in cancer.
- Discussion of therapeutic strategies including targeted therapies and immunotherapy.
- Examination of host factors influencing treatment response.
Main Results:
- Precision oncology necessitates personalized treatment tailored to individual molecular and immune profiles.
- Omic analyses are vital for matching patients with the most effective immune-targeted drugs.
- Understanding the host's role is critical for maximizing immunotherapy impact.
- Deleterious mutations in normal tissues and non-malignant conditions complicate treatment choices.
Conclusions:
- Optimizing precision oncology requires addressing complex molecular and immune interactions.
- Personalized drug combinations and treatment timing are critical for efficacy.
- Further research is needed to solve key riddles in applying precision medicine to lethal cancers.
- Integrating omic data with host factors will enhance treatment selection and patient outcomes.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

